by University of Chicago Medical Center Aneuploidy and TMB are synergistic predictors of survival following immunotherapy. Credit: Nature Genetics (2022). DOI: 10.1038/s41588-022-01235-4 In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking they are healthy cells....
